23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in campylobacter jejuni

Microbial Drug Resistance

Volumn 15, Issue 4, 2009, Pages 239-244

  Hao, Haihong ^a   Dai, Menghong ^a   Wang, Yulian ^a   Peng, Dapeng ^a   Liu, Zhenli ^a   Yuan, Zonghui ^a  

^a MOA Key Laboratory of Food Safety Evaluation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; RNA 23S; TYLOSIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; GENE MUTATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; TYLOSIN;

CAMPYLOBACTER JEJUNI;

EID: 70350443397     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0008     Document Type: Article

References (30)

1. Aarestrup, F.M., E.M. Nielsen, M. Madsen, and J. Engberg. 1997. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob. Agents Chemother. 41:2244-2250.
2. Allos, B.M. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin. Infect. Dis. 32:1201-1206.
3. Altekruse, S.F., N.J. Stern, P.I. Fields, and D.L. Swerdlow. 1999. Campylobacter jejuni-an emerging foodborne pathogen. Emerg. Infect. Dis. 5:28-35.
4. Bae, W., K.N. Kaya, D.D. Hancock, D.R. Call, Y.H. Park, and T.E. Besser. 2005. Prevalence and antimicrobial resistance of thermophilic Campylobacter spp. from cattle farms in Washington State. Appl. Environ. Microbiol. 71:169-174.
5. Blaser, M.J. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J. Infect. Dis. 176 Suppl 2:S103-S105.
6. Blaser, M.J., D.N. Taylor, and R.A. Feldman. 1983. Epidemiology of Campylobacter jejuni infections. Epidemiol. Rev. 5:157-176.
7. Bogdanovich, T., L.M. Ednie, S. Shapiro, and P.C. Appelbaum. 2005. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 49:4210-4219. (Pubitemid 41400966)
8. Cagliero, C., C. Mouline, A. Cloeckaert, and S. Payot. 2006. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 50:3893-3896.
9. Caldwell, D.B., Y. Wang, and J. Lin. 2008. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 52:3947-3954.
10. Fouts, D.E., E.F. Mongodin, R.E. Mandrell, W.G. Miller, D.A. Rasko, J. Ravel, L.M. Brinkac, R.T. DeBoy, C.T. Parker, S.C. Daugherty, R.J. Dodson, A.S. Durkin, R. Madupu, S.A. Sullivan, J.U. Shetty, M.A. Ayodeji, A. Shvartsbeyn, M.C. Schatz, J.H. Badger, C.M. Fraser, and K.E. Nelson. 2005. Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol. 3:e15.
11. Gagneux, S., C.D. Long, P.M. Small, T. Van, G.K. Schoolnik, and B.J. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946.
12. Gibreel, A., V.N. Kos, M. Keelan, C.A. Trieber, S. Levesque, S. Michaud, and D.E. Taylor. 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49:2753-2759.
13. Gibreel, A., and D.E. Taylor. 2006. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 58:243-255.
14. Homma, T., T. Hori, G. Sugimori, and Y. Yamano. 2007. Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51:3810-3815.
15. Jensen, L.B., and F.M. Aarestrup. 2001. Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrob. Agents Chemother. 45:371-372.
16. Kanai, K., K. Shibayama, S. Suzuki, J. Wachino, and Y. Arakawa. 2004. Growth competition of macrolide-resistant and -susceptible Helicobacter pylori strains. Microbiol. Immunol. 48:977-980.
17. Kosowska, K., D.B. Hoellman, G. Lin, C. Clark, K. Credito, P. McGhee, B. Dewasse, B. Bozdogan, S. Shapiro, and P.C. Appelbaum. 2005. Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 49:1932-1942. (Pubitemid 40631609)
18. Ladely, S.R., R.J. Meinersmann, M.D. Englen, P.J. Fedorka- Cray, and M.A. Harrison. 2008. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli. Foodborne Pathog. Dis. 6:91-98.
19. Levin, B.R., V. Perrot, and N. Walker. 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985-997.
20. Lin, J., M. Yan, O. Sahin, S. Pereira, Y.J. Chang, and Q. Zhang. 2007. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob. Agents Chemother. 51:1678-1686.
21. Luo, N., S. Pereira, O. Sahin, J. Lin, S. Huang, L. Michel, and Q. Zhang. 2005. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. USA 102:541-546.
22. Mamelli, L., V. Prouzet-Mauleon, J.M. Pages, F. Megraud, and J.M. Bolla. 2005. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J. Antimicrob. Chemother. 56:491-497.
23. Orr, H.A. 2005. Theories of adaptation: what they do and don't say. Genetica 123:3-13.
24. Parkhill, J., B.W. Wren, K. Mungall, J.M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R.M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A.V. Karlyshev, S. Moule, M.J. Pallen, C.W. Penn, M.A. Quail, M.A. Rajandream, K.M. Rutherford, A.H. van Vliet, S. Whitehead, and B.G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
25. Perfeito, L., L. Fernandes, C. Mota, and I. Gordo. 2007. Adaptive mutations in bacteria: high rate and small effects. Science 317:813-815.
26. Reina, J., N. Borrell, and A. Serra. 1992. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991. Eur. J. Clin. Microbiol. Infect. Dis. 11:1163-1166.
27. Reynolds, M.G. 2000. Compensatory evolution in rifampinresistant Escherichia coli. Genetics 156:1471-1481.
28. Segreti, J., T.D. Gootz, L.J. Goodman, G.W. Parkhurst, J.P. Quinn, B.A. Martin, and G.M. Trenholme. 1992. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J. Infect. Dis. 165:667-670.
29. Wickman, P.A., J.A. Black, E. Smith Moland, K.S. Thomson, and N.D. Hanson. 2006. In vitro development of resistance to DX-619 and other quinolones in enterococci. J. Antimicrob. Chemother. 58:1268-1273.
30. Yang, C., Y. Jiang, K. Huang, C. Zhu, Y. Yin, J.H. Gong, and H. Yu. 2004. A real-time PCR assay for the detection and quantitation of Campylobacter jejuni using SYBR Green I and the LightCycler. Yale J. Biol. Med. 77:125-132.